Glover Nicholas 4
4 · MEI Pharma, Inc. · Filed Jul 17, 2025
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Glover Nicholas
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-07-15+20,000→ 20,000 totalExercise: $3.07From: 2025-07-15Exp: 2035-07-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.